Megan Lim, MD, PhD, is a professor of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania. She is the director of the Division of Hematopathology at the Hospital of the University of Pennsylvania and co-leader for the Lymphoma Translational Center for Excellence at the Abramson Cancer Center.
Dr. Lim received an MD from the University of Calgary and a PhD in molecular oncology from the University of Calgary and National Cancer Institute Lab of Pathology, jointly. She obtained her hematopathology fellowship training at the National Cancer Institute and is a diplomate of the American Board of Pathology with a subspecialty in hematopathology and molecular genetic pathology. Dr. Lim assumed a faculty position at the University of Toronto (1998-2000) and then at the University of Utah (2000-2006). At the University of Michigan (2006-2015), she was the Director of Hematopathology and of the hematopathology fellowship program. Dr. Lim has held numerous leadership positions and served on training and education committees for the Association of Molecular Pathology and the United States Academy of Pathology. She is a member of the Board of Directors for the United States and Canadian Academy of Pathology, and the vice-chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Group.
Dr. Lim’s research has garnered extramural support from the National Institutes of Health and foundations. Her research utilizes large-scale mass spectrometry-based proteomic profiling and genomic analysis to characterize novel pathogenetic mechanisms in lymphomas, with a focus on lymphoid neoplasms in the pediatric, adolescent, and young adult population. Dr. Lim has authored more than 170 peer-reviewed articles and is co-editor of the Armed Forces Institute of Pathology’s “Tumors of the Lymph Nodes and Spleen: Electronic Fascicle.”